Business
Innovest Global Inc. to Launch Biotech and Health Sciences Division Led by World Renowned Neuroscientist, Dr. Dwain Morris-Irvin
Innovest Global Inc. to Launch Biotech and Health Sciences Division Led by World Renowned Neuroscientist, Dr. Dwain Morris-Irvin.
About this update from Innovest Global Inc
[{"type":"text","content":"\n\n CLEVELAND, March 05, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC PINK:IVST) is pleased to announce that it has tapped Dr. Dwain Morris-Irvin, PhD MPH, to launch a Biotechnology and Health Sciences division for Innovest this spring, to be headquartered in Los Angeles, CA. The division expects to have ownership in technologies that have the potential to be significantly valuable.\n With this development to its diversified model, Innovest has defined its second industry focus: Biotechnology and Health Sciences. Innovest will now have a beachhead from which they can accumulate interests in up-and-coming biotech and health science intellectual property, patents, and initiatives; and generate revenue from associated activities. This division adds a second leg to operations that are currently focused on reliable revenue streams from a commercial and industrial client base in the areas of energy, and durable goods. Dr. Morris-Irvin is an active participant in many Biotechnology and Health Science endeavors, and is an expert including patent generation in such areas as treatments for Parkinson’s, brain cancer, and even cosmetic application of advanced bioscience. He is also an expert in the physical operations of laboratories, and hospitals. He received his PhD from UCLA School of Medicine, and Masters in Public Health from UCLA School of Public Health, and trained at The Wallenberg Neuroscience Center at Lund University in Lund, Sweden. He was also a Professor, Faculty member at Cedars-Sinai Medical Center, Department of Neurosurgery. Dr. Morris-Irvin has significant enthusiasm for this effort, “Dan Martin (CEO of Innovest) has a demonstrated history of adding business value to Health Science organizations I have led in the past, that have resulted in improved quality of life for people. His proven commitment to scientific advancement and his ability to execute in business, are why I am so excited about the potential we have to use the well-structured Innovest model, to create significant value. Value not only for Innovest shareholders; but for the public interest at large and the scientists and organizations behind general health and biotechnology initiatives around the world.” “Dr. Morris-Irvin has a unique combination of subject matter expertise, experience, and business acumen that make him a perf...